Global Atorvastatin Market Size, by Type (Tablet, Capsule), by Application (Cardiovascular Disorders, Obesity), & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1012241
  • |
  • Publishe Date : May 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Atorvastatin market was estimated to be valued at USD XX million in 2019 and is projected to reach USD XX million by 2029, at a CAGR of XX% during 2019 to 2026. Rise in the prevalence of cholesterol owing to changing lifestyle and increasing healthcare awareness are factors augmenting the atorvastatin market globally. However, presence of alternative drugs is one of the major factors impeding the growth of the market.

The global atorvastatin market is primarily segmented based on different type, application, and regions.

On the basis of type, the market is split into:
* Tablet
* Capsule

On the basis of application, the market is split into:
* Cardiovascular Disorders
* Obesity
* Others

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Pfizer
* Centrient Pharmaceuticals
* Cadila Pharmaceuticals
* Sun Pharmaceutical Industries
* MSN Laboratories
* Dr. Reddys
* Teva Pharmaceutical Industries
* Apotex Pharmachem
* Zhejiang New Dankong Pharmaceutical Co., Ltd.
* Jialin Pharmaceutical

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, type, and application market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, type, and application with qualitative and quantitative information and facts

Target Audience:
* Atorvastatin Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Atorvastatin Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Atorvastatin Market - Porter\'s Five Forces Analysis
4.4. Global Atorvastatin Market - PESTEL Analysis

5. Global Atorvastatin Market, by Type
5.1. Global Atorvastatin Market, Size and Forecast, 2015-2026
5.2. Global Atorvastatin Market, by Tablet, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Atorvastatin Market, by Capsule, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026

6. Global Atorvastatin Market, by Application
6.1. Global Atorvastatin Market, Size and Forecast, 2015-2026
6.2. Global Atorvastatin Market, for Cardiovascular Disorders, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Atorvastatin Market, for Obesity, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Atorvastatin Market, for Other Applications, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026

7. Global Atorvastatin Market, by Region
7.1. Atorvastatin Market Regional Analysis, 2015-2026
7.2. Global Atorvastatin Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Atorvastatin Market, 2015-2026
7.3.1. North America Atorvastatin Market Size and Forecast, 2015-2026
7.3.2. North America Atorvastatin Market by Country, 2015-2026
7.3.2.1. U.S. Atorvastatin Market, 2015-2026
7.3.2.2. Canada Atorvastatin Market, 2015-2026
7.4. Europe Atorvastatin Market, 2015-2026
7.4.1. Europe Atorvastatin Market Size and Forecast, 2015-2026
7.4.2. Europe Atorvastatin Market by Country, 2015-2026
7.4.2.1. Germany Atorvastatin Market, 2015-2026
7.4.2.2. France Atorvastatin Market, 2015-2026
7.4.2.3. Italy Atorvastatin Market, 2015-2026
7.4.2.4. UK Atorvastatin Market, 2015-2026
7.4.2.5. Spain Atorvastatin Market, 2015-2026
7.4.2.6. Rest of Europe Atorvastatin Market, 2015-2026
7.5. Asia Pacific Atorvastatin Market, 2015-2026
7.5.1. Asia Pacific Atorvastatin Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Atorvastatin Market by Country, 2015-2026
7.5.2.1. Japan Atorvastatin Market, 2015-2026
7.5.2.2. China Atorvastatin Market, 2015-2026
7.5.2.3. India Atorvastatin Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Atorvastatin Market, 2015-2026
7.6. South America Atorvastatin Market, 2015-2026
7.6.1. South America Atorvastatin Market Size and Forecast, 2015-2026
7.6.2. South America Atorvastatin Market by Country, 2015-2026
7.6.2.1. Mexico Atorvastatin Market, 2015-2026
7.6.2.2. Brazil Atorvastatin Market, 2015-2026
7.6.2.3. Rest of South America Atorvastatin Market, 2015-2026
7.7. Middle East & Africa Atorvastatin Market, 2015-2026
7.7.1. Middle East & Africa Atorvastatin Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Atorvastatin Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Atorvastatin Market, 2015-2026
7.7.2.2. South Africa Atorvastatin Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Atorvastatin Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2019

9. Company Profiles
9.1. Pfizer
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. DSM Sinochem Pharmaceuticals
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Cadila Pharmaceuticals
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Sun Pharmaceutical Industries
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. MSN Laboratories
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Dr. Reddys
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Teva Pharmaceutical Industries
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Apotex Pharmachem
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Zheijang Neo-Dankon Pharmaceutical
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Jialin Pharmaceutical
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type